Experimental liver fibrosis research: update on animal models, legal issues and translational aspects

作者: Christian Liedtke , Tom Luedde , Tilman Sauerbruch , David Scholten , Konrad Streetz

DOI: 10.1186/1755-1536-6-19

关键词:

摘要: Liver fibrosis is defined as excessive extracellular matrix deposition and based on complex interactions between matrix-producing hepatic stellate cells an abundance of liver-resident infiltrating cells. Investigation these processes requires in vitro vivo experimental work animals. However, the use animals translational research will be increasingly challenged, at least countries European Union, because adoption new animal welfare rules 2013. These create urgent need for optimized standard operating procedures regarding experimentation improved international communication liver community. This review gives update current models, techniques underlying pathomechanisms with aim fostering a critical discussion limitations potential up-to-date experimentation. We discuss complications provide examples how findings studies which models are used can translated to human disease therapy. In this review, we want motivate community design more standardized might help address legally requested replacement, refinement reduction research.

参考文章(220)
Catherine A. Schuppli, David Fraser, Michael McDonald, Expanding the Three Rs to Meet New Challenges in Humane Animal Experimentation Atla-alternatives To Laboratory Animals. ,vol. 32, pp. 525- 532 ,(2004) , 10.1177/026119290403200507
P. M. Sutton, Elizabeth K. McLean, A. E. M. McLean, Instant Cirrhosis: An Improved Method for Producing Cirrhosis of the Liver in Rats by Simultaneous Administration of Carbon Tetrachloride and Phenobarbitone British journal of experimental pathology. ,vol. 50, pp. 502- 506 ,(1969)
Juan G Abraldes, Marcos Pasarín, Juan Carlos García-Pagán, Animal models of portal hypertension World Journal of Gastroenterology. ,vol. 12, pp. 6577- 6584 ,(2006) , 10.3748/WJG.V12.I41.6577
Stock Mk, do O Nt, Alsamman M, Sahin H, Tacke F, Wasmuth He, Heinrichs D, Hammerich L, Trautwein C, Nellen A, Berres Ml, Met-CCL5 modifies monocyte subpopulations during liver fibrosis regression. International Journal of Clinical and Experimental Pathology. ,vol. 6, pp. 678- 685 ,(2013)
Thais H Mauad, Carin MJ Van Nieuwkerk, Koert P Dingemans, Jaap JM Smit, Alfred H Schinkel, Robbert GE Notenboom, Marius A van den Bergh Weerman, Ronald P Verkruisen, Albert K Groen, Ronald PJ Oude Elferink, Martin A Van Der Valk, Piet Borst, G Johan A Offerhaus, Mice with homozygous disruption of the mdr2 P-glycoprotein gene. A novel animal model for studies of nonsuppurative inflammatory cholangitis and hepatocarcinogenesis. American Journal of Pathology. ,vol. 145, pp. 1237- 1245 ,(1994)
N C Nayak, K G Ishak, H E Poulsen, P P Anthony, P J Scheuer, L H Sobin, The morphology of cirrhosis: definition, nomenclature, and classification. Bulletin of The World Health Organization. ,vol. 55, pp. 521- 540 ,(1977)
M Pinzani, S Pastacaldi, G Laffi, R DeFranco, F Marra, R G Romanelli, S Milani, P Gentilini, C Grappone, Increased expression of monocyte chemotactic protein-1 during active hepatic fibrogenesis: correlation with monocyte infiltration. American Journal of Pathology. ,vol. 152, pp. 423- 430 ,(1998)
Andrea Bonacchi, Ilaria Petrai, Raffaella M.S Defranco, Elena Lazzeri, Francesco Annunziato, Eva Efsen, Lorenzo Cosmi, Paola Romagnani, Stefano Milani, Paola Failli, Giacomo Batignani, Francesco Liotta, Giacomo Laffi, Massimo Pinzani, Paolo Gentilini, Fabio Marra, The chemokine CCL21 modulates lymphocyte recruitment and fibrosis in chronic hepatitis C Gastroenterology. ,vol. 125, pp. 1060- 1076 ,(2003) , 10.1016/S0016-5085(03)01194-6
Caroline Romestaing, Marie-Astrid Piquet, Elodie Bedu, Vincent Rouleau, Marianne Dautresme, Isabelle Hourmand-Ollivier, Céline Filippi, Claude Duchamp, Brigitte Sibille, Long term highly saturated fat diet does not induce NASH in Wistar rats. Nutrition & Metabolism. ,vol. 4, pp. 4- 4 ,(2007) , 10.1186/1743-7075-4-4